Injectable Drug Articles & Analysis
16 articles found
In the process of new drug development, the study of pharmacokinetics is of great significance. The result can be used to guide the screening and development of drugs, and support the evaluation of their safety and the design of clinical drug delivery protocol. ...
This structure mimics the cell membrane, allowing liposomes to seamlessly interact with cells. Why use liposomes for drug delivery? Traditional drug delivery methods, like pills and injections, often have drawbacks. ...
On February 24, 2023, The NMPA approved Enhertu, an injectable drug developed jointly by AstraZeneca and Daiichi Sankyo, for the treatment of adults with unresectable or metastatic HER2-positive breast cancer who have previously received one or more anti-HER2 drugs. Dertrastuzumab is an antibody-drug conjugate (ADC) ...
The GLP-1 analogues have established themselves in the past years as one of the superior drug classes for treatment of diabetes type II in terms of blood glucose lowering and weight loss. Because of the latter, they are being used more and more also in the treatment of obesity. Until now, both drugs are only available by injection. With the ...
It can be said that without excipients, there will be no pharmaceutical preparations, let alone different pharmaceutical dosage forms such as powders, granules, tablets, oral liquids or injections. When the drug and the appropriate excipients are combined into a specific dosage form, the drug would become safer, more stable and more convenient to ...
Blueberry were recently invited to write two commentaries on the challenges of treating skin and nail diseases and the potential for nanotechnology approaches in dermal drug delivery. Here we share a brief overview of these articles. We will all have encountered someone who is dealing with or has previously experienced a common ailment of the skin or nails, such as eczema (atopic dermatitis), ...
Typical biologic concentrations are ≤200 mg/mL; with increased dose needs there becomes a trade-off between concentration which leads to higher drug volume or viscosity, which results in drug-delivery solutions that either take more time or force to inject. ...
It can be said that without excipients, there will be no pharmaceutical preparations, let alone different pharmaceutical dosage forms such as powders, granules, tablets, oral liquids or injections. When the drug and the appropriate excipients are combined into a specific dosage form, the drug would become safer, more stable and more convenient to ...
Biologics are among the top-selling therapeutics on the market, making up eight of the top 10 selling drugs. All biologics are injected using either subcutaneous, intramuscular or intravenous routes. ...
Rani Therapeutics offers a breakthrough capsule, the RaniPill which could change the way patients with chronic conditions take medication by eliminating the need for painful injections. Rani Therapeutics is a clinical-stage biotherapeutics company offering an alternative to painful injections for patients with chronic conditions such as neuroendocrine ...
There is evidence for some conditions suggesting patients prefer oral drugs to injections: for example, studies on cancer patients have illuminated patient preference for oral therapies rather than regular injections. ...
Rani, A Platform Technology Company: Rani's proprietary platform technology, the RaniPill capsule, intends to replace subcutaneous or intravenous injections of biologics with oral dosing. RaniPill helps convert injectable biologic drugs such as TNF-alpha inhibitors, interleukin antibodies and basal insulin, among others, into pills. ...
The company, which specializes in making critical-need injectable medications more available, partnered with MECO, choosing the MASTERfit water purification system for its pharmaceutical production. The Nexus manufacturing facility is the only project of its kind in the sterile generic injectables industry in the last 30 years. Construction began in 2019 for the ...
Nurses need "three checks and seven pairs" in the process of dispensing drugs and injections. Among them, patients' names are checked to prevent misuse of drugs. ...
Could this new drug delivery system for tranexamic acid optimize melasma treatment? ...
According to the BOP, “certain risks and conditions, such as HIV infection, diabetes, chronic renal failure, injection drug use history, and close contact with someone who is sick with infectious TB, all pose a greater risk for getting TB ...
ByE-CO